in8bio
in8bio
IN8bio is a clinical-stage biopharmaceutical company focused on advancing the next generation of cellular therapies. The company specializes in the discovery, development, and commercialization of gamma-delta T cell therapies designed to treat both solid and hematologic cancers.
